245 related articles for article (PubMed ID: 35687817)
1. Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II Expression.
Han G; Deng Q; Marques-Piubelli ML; Dai E; Dang M; Ma MCJ; Li X; Yang H; Henderson J; Kudryashova O; Meerson M; Isaev S; Kotlov N; Nomie KJ; Bagaev A; Parra ER; Solis Soto LM; Parmar S; Hagemeister FB; Ahmed S; Iyer SP; Samaniego F; Steiner R; Fayad L; Lee H; Fowler NH; Flowers CR; Strati P; Westin JR; Neelapu SS; Nastoupil LJ; Vega F; Wang L; Green MR
Blood Cancer Discov; 2022 Sep; 3(5):428-443. PubMed ID: 35687817
[TBL] [Abstract][Full Text] [Related]
2. Mass Cytometry of Follicular Lymphoma Tumors Reveals Intrinsic Heterogeneity in Proteins Including HLA-DR and a Deficit in Nonmalignant Plasmablast and Germinal Center B-Cell Populations.
Wogsland CE; Greenplate AR; Kolstad A; Myklebust JH; Irish JM; Huse K
Cytometry B Clin Cytom; 2017 Jan; 92(1):79-87. PubMed ID: 27933753
[TBL] [Abstract][Full Text] [Related]
3. Single-cell RNA-Seq of follicular lymphoma reveals malignant B-cell types and coexpression of T-cell immune checkpoints.
Andor N; Simonds EF; Czerwinski DK; Chen J; Grimes SM; Wood-Bouwens C; Zheng GXY; Kubit MA; Greer S; Weiss WA; Levy R; Ji HP
Blood; 2019 Mar; 133(10):1119-1129. PubMed ID: 30591526
[TBL] [Abstract][Full Text] [Related]
4. T Cells Expressing Checkpoint Receptor TIGIT Are Enriched in Follicular Lymphoma Tumors and Characterized by Reversible Suppression of T-cell Receptor Signaling.
Josefsson SE; Huse K; Kolstad A; Beiske K; Pende D; Steen CB; Inderberg EM; Lingjærde OC; Østenstad B; Smeland EB; Levy R; Irish JM; Myklebust JH
Clin Cancer Res; 2018 Feb; 24(4):870-881. PubMed ID: 29217528
[No Abstract] [Full Text] [Related]
5. Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cells.
Amé-Thomas P; Le Priol J; Yssel H; Caron G; Pangault C; Jean R; Martin N; Marafioti T; Gaulard P; Lamy T; Fest T; Semana G; Tarte K
Leukemia; 2012 May; 26(5):1053-63. PubMed ID: 22015774
[TBL] [Abstract][Full Text] [Related]
6. Follicular lymphoma B cells exhibit heterogeneous transcriptional states with associated somatic alterations and tumor microenvironments.
Krull JE; Wenzl K; Hopper MA; Manske MK; Sarangi V; Maurer MJ; Larson MC; Mondello P; Yang Z; Novak JP; Serres M; Whitaker KR; Villasboas Bisneto JC; Habermann TM; Witzig TE; Link BK; Rimsza LM; King RL; Ansell SM; Cerhan JR; Novak AJ
Cell Rep Med; 2024 Mar; 5(3):101443. PubMed ID: 38428430
[TBL] [Abstract][Full Text] [Related]
7. Patient-derived lymphoma spheroids integrating immune tumor microenvironment as preclinical follicular lymphoma models for personalized medicine.
Faria C; Gava F; Gravelle P; Valero JG; Dobaño-López C; Van Acker N; Quelen C; Jalowicki G; Morin R; Rossi C; Lagarde JM; Fournié JJ; Ysebaert L; Laurent C; Pérez-Galán P; Bezombes C
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37899130
[TBL] [Abstract][Full Text] [Related]
8. The Tumor Microenvironment in Follicular Lymphoma: Its Pro-Malignancy Role with Therapeutic Potential.
Watanabe T
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069564
[TBL] [Abstract][Full Text] [Related]
9. A human lymphoma organoid model for evaluating and targeting the follicular lymphoma tumor immune microenvironment.
Kastenschmidt JM; Schroers-Martin JG; Sworder BJ; Sureshchandra S; Khodadoust MS; Liu CL; Olsen M; Kurtz DM; Diehn M; Wagar LE; Alizadeh AA
Cell Stem Cell; 2024 Mar; 31(3):410-420.e4. PubMed ID: 38402619
[TBL] [Abstract][Full Text] [Related]
10. Single-Cell Transcriptome Analysis Reveals Disease-Defining T-cell Subsets in the Tumor Microenvironment of Classic Hodgkin Lymphoma.
Aoki T; Chong LC; Takata K; Milne K; Hav M; Colombo A; Chavez EA; Nissen M; Wang X; Miyata-Takata T; Lam V; Viganò E; Woolcock BW; Telenius A; Li MY; Healy S; Ghesquiere C; Kos D; Goodyear T; Veldman J; Zhang AW; Kim J; Saberi S; Ding J; Farinha P; Weng AP; Savage KJ; Scott DW; Krystal G; Nelson BH; Mottok A; Merchant A; Shah SP; Steidl C
Cancer Discov; 2020 Mar; 10(3):406-421. PubMed ID: 31857391
[TBL] [Abstract][Full Text] [Related]
11. Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation.
Green MR; Kihira S; Liu CL; Nair RV; Salari R; Gentles AJ; Irish J; Stehr H; Vicente-Dueñas C; Romero-Camarero I; Sanchez-Garcia I; Plevritis SK; Arber DA; Batzoglou S; Levy R; Alizadeh AA
Proc Natl Acad Sci U S A; 2015 Mar; 112(10):E1116-25. PubMed ID: 25713363
[TBL] [Abstract][Full Text] [Related]
12. Distinct clinical and genetic features of hepatitis B virus-associated follicular lymphoma in Chinese patients.
Ren W; Wang X; Yang M; Wan H; Li X; Ye X; Meng B; Li W; Yu J; Lei M; Xie F; Jiang W; Kimby E; Huang H; Liu D; Li ZM; Wu K; Zhang H; Pan-Hammarström Q
Blood Adv; 2022 May; 6(9):2731-2744. PubMed ID: 35030632
[TBL] [Abstract][Full Text] [Related]
13. Cathepsin S Alterations Induce a Tumor-Promoting Immune Microenvironment in Follicular Lymphoma.
Bararia D; Hildebrand JA; Stolz S; Haebe S; Alig S; Trevisani CP; Osorio-Barrios F; Bartoschek MD; Mentz M; Pastore A; Gaitzsch E; Heide M; Jurinovic V; Rautter K; Gunawardana J; Sabdia MB; Szczepanowski M; Richter J; Klapper W; Louissaint A; Ludwig C; Bultmann S; Leonhardt H; Eustermann S; Hopfner KP; Hiddemann W; von Bergwelt-Baildon M; Steidl C; Kridel R; Tobin JWD; Gandhi MK; Weinstock DM; Schmidt-Supprian M; Sárosi MB; Rudelius M; Passerini V; Mautner J; Weigert O
Cell Rep; 2020 May; 31(5):107522. PubMed ID: 32330423
[TBL] [Abstract][Full Text] [Related]
14. Grade I, II and III Follicular Lymphomas Express Ig V
Csernus B; Timár B; Fülöp Z; Matolcsy A
Pathol Oncol Res; 2020 Oct; 26(4):2765-2772. PubMed ID: 32705429
[TBL] [Abstract][Full Text] [Related]
15. BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma.
Burkhard R; Bhagat G; Cogliatti SB; Rossi D; Gaidano G; Pasqualucci L; Novak U
Hematol Oncol; 2015 Mar; 33(1):23-30. PubMed ID: 24496723
[TBL] [Abstract][Full Text] [Related]
16. Expression of KLRG1 and CD127 defines distinct CD8
Wu H; Tang X; Kim HJ; Jalali S; Pritchett JC; Villasboas JC; Novak AJ; Yang ZZ; Ansell SM
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34226281
[TBL] [Abstract][Full Text] [Related]
17. Revealing the evolution of the tumor immune microenvironment in follicular lymphoma patients progressing within 24 months using single-cell imaging mass cytometry.
Liu L; Yu X; Li Z; He X; Zha J; Lin Z; Hong Y; Zheng H; Lai Q; Ding K; Jia X; Fu G; Yu H; Yang H; Li Z; Young KH; Xu B
J Hematol Oncol; 2022 Aug; 15(1):115. PubMed ID: 35996180
[TBL] [Abstract][Full Text] [Related]
18. Follicular lymphoma cells induce changes in T-cell gene expression and function: potential impact on survival and risk of transformation.
Kiaii S; Clear AJ; Ramsay AG; Davies D; Sangaralingam A; Lee A; Calaminici M; Neuberg DS; Gribben JG
J Clin Oncol; 2013 Jul; 31(21):2654-61. PubMed ID: 23775959
[TBL] [Abstract][Full Text] [Related]
19. The yin and the yang of follicular lymphoma cell niches: role of microenvironment heterogeneity and plasticity.
Amé-Thomas P; Tarte K
Semin Cancer Biol; 2014 Feb; 24():23-32. PubMed ID: 23978491
[TBL] [Abstract][Full Text] [Related]
20. Indolent lymphoma: follicular lymphoma and the microenvironment-insights from gene expression profiling.
Rimsza LM; Jaramillo MC
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):163-8. PubMed ID: 25696850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
